Neutropenic Fever, Skin and Eye Toxicities Develops During Docetaxel Treatment in Metastatic Prostate Cancer: A Case Report

Basit Öğe Kaydı
dc.contributor.authorSen, Erdem
dc.contributor.authorOner, Irem
dc.contributor.authorAta, Ozlem
dc.date.accessioned2020-03-26T19:42:08Z
dc.date.available2020-03-26T19:42:08Z
dc.date.issued2017
dc.departmentSelçuk Üniversitesien_US
dc.description.abstractProstate cancer is one of the most common tumors in men. Docetaxel and prednisone treatment are accepted as standard therapy in castration-resistant prostate cancer patients. Docetaxel is a chemotherapeutic drug of the taxane group that inhibits depolymerization of tubulin and has an antitumoral activity through stabilization of microtubules. It has also been reported that docetaxel therapy lead to cutaneous and eye side effects besides systemic side effects. Skin and eye toxicities are more common with weekly docetaxel treatment than three-week regimens. We would like to present our case of neutropenia, eye and skin toxicities with docetaxel chemotherapy treatment which is commonly used in metastatic prostate cancer patients.en_US
dc.identifier.doi10.4274/uob.908en_US
dc.identifier.endpage136en_US
dc.identifier.issn2147-2270en_US
dc.identifier.issue4en_US
dc.identifier.pmid#YOKen_US
dc.identifier.startpage133en_US
dc.identifier.urihttps://dx.doi.org/10.4274/uob.908
dc.identifier.urihttps://hdl.handle.net/20.500.12395/35316
dc.identifier.volume16en_US
dc.identifier.wosWOS:000419741500007en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isotren_US
dc.publisherGALENOS YAYINCILIKen_US
dc.relation.ispartofUROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGYen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.selcuk20240510_oaigen_US
dc.subjectProstate canceren_US
dc.subjectconjunctivitisen_US
dc.subjectdocetaxelen_US
dc.titleNeutropenic Fever, Skin and Eye Toxicities Develops During Docetaxel Treatment in Metastatic Prostate Cancer: A Case Reporten_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu